Navigation Links
Genedata at HCA Announces Banner Year for Genedata Screener at Leading Pharmaceutical Companies
Date:1/11/2010

S at high throughputs. Several customers report that Screener HCS enables them to easily process 1,000,000 compounds or more per screen. This is a result of Screener's ability to leverage this information within a scalable framework, which features automated data processing and intelligent management functions - all of which can be reviewed by scientists at any stage in the process. "2009 was a banner year for HCS adoption," continued Pfannes, "and I project that 2010 will be the year in which we see HCS in far more rigorous production settings as well as continued adoption by customers looking for a scalable HCS technology."

Screener standardizes and automates in-depth analysis of high content screens passing from single-cell data to hit selection in a highly efficient workflow. The increased throughput of Screener HCS and user-friendly interface for visualization, management, and review allows researchers and scientists to review more cellular images in less time and quickly identify subtle variances. While Screener is fully compatible with the Thermo Scientific Cellomics Store image management system, it has also been integrated with other in-house and commercial HCS image storage solutions.

Note to Editors: Genedata will deliver a presentation on how to establish a routine application of HCS in high throughput screening at HCA on January 13th at 1:00 p.m. To schedule an editorial briefing, email Jackie.Thrasivoulos@genedata.com.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery and life science research, which spans target, lead and biomarker discovery. Used by a majority of the world's top 50 pharmaceutical companies and leading research organizations, Genedata Phyloso
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities
2. Genedata Expressionist with New Transcriptomics Biomarker Capabilities Advances Drug Development for Personalized Medicine
3. Genedata Screener Supports Small Molecule Research at the Broad Institute of Harvard and MIT
4. Genedata and the Institute of Experimental Medicine, Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project
5. MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... today announced that it will release fourth quarter and ... March 10, 2015 after the close of the U.S. ... and webcast on Tuesday, March 10, 2015 at 4:30 ... results and recent corporate developments. For both ...
(Date:3/2/2015)... Global Stem Cells Group.com ... Shenzhen HANK Bioengineering Co., Ltd. and its Chinese-American ... establish a stem cells training course in the ... 2015. , Shenzhen HANK is a biotechnology company ... microbiologist and virologist, to integrate research, development, production, ...
(Date:2/28/2015)... Increasing its efforts to resolve the ... three episodes of The GMO TRUTH podcast on both ITunes ... it continues its mission to discover the truth and change ... to “uncover the truth about the GMOs in our food ... Truth Podcast is an expansion of the documentary/investigative film-making methodology ...
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... its newly developed Bruton,s tyrosine kinase (BTK) inhibitor ... The results of these preclinical evaluations have been ... The feedback received from the Agency is supportive ... Additional preclinical work is required to begin a ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
... Monogram announces availability of HERmark and HER1 and HER3 ... Assays ... June 2 Monogram,Biosciences, Inc. (Nasdaq: MGRM ) ... on HERmark(TM),the company,s novel oncology assay, as a means ...
... (TSH),Canada,s largest urban community hospital, has selected Chyma(TM) ... The,implementation of Chyma(TM) for their team of more ... departments at the two hospital campuses and will,soon ... "Chyma(TM) reflects the commitment of the Scarborough ...
... 2 The following release was,issued today by Thomas P. ... the New York State Common Retirement Fund, the Lead Plaintiff,in ... UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA ... MCK ) SECURITIES LITIGATION, Master File No. 99-CV-20743 ...
Cached Biology Technology:Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 2Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 3Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 4Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 5Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 6Canada's Largest Urban Community Hospital Chooses Chyma(TM) On-Call Physician Scheduling Technology 2Notice of Initial Distribution of Net Settlement Funds 2Notice of Initial Distribution of Net Settlement Funds 3
(Date:2/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND ... new groundbreaking payment method. Payment accounts may be selected ... be accessed if both the speech (the word associated ...
(Date:2/18/2015)... Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... speaking at the following conferences, and invited investors to participate ... Boston, MA Tuesday, March 3, 2015 ... Investors Conference, Orlando, FL Wednesday, March ... Live Webcasts To access the live webcasts for these events, ...
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... call; most lack or have only rudimentary vocal cords. A ... and then silently signals her beau. But the female ... of declaring her interest: She emits a high-pitched chirp that ... This is one of several unusual frog-related findings reported ...
... and Java ... ... high-precision biometric identification technologies, today announced,the availability of MegaMatcher 2.1 ... and multi-biometric,face-fingerprint identification systems. MegaMatcher 2.1 includes a number,of new ...
... N.J., May 9 BIO-key International, Inc.,(OTC Bulletin Board: BKYI) ... Thursday, May 15, 2008 before the market opens.,In conjunction with ... broadcast live over the Internet on Thursday, May 15, 2008 ... International, Inc. First Quarter 2008 Earnings Conference ...
Cached Biology News:Female concave-eared frogs draw mates with ultrasonic calls 2Female concave-eared frogs draw mates with ultrasonic calls 3Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 2Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 3Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 4BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule 2
... Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA ... Assay: TLC ≥ 90 % Cation traces: Ca ... 5 mg/kg Cr ≤ 5 mg/kg Cu ≤ 5 ... Mg ≤ 5 mg/kg Mn ≤ 5 mg/kg Na ...
BioGenex IHC Kits for Rodent Tissues are designed for immunohistochemistry on rodent and rabbit tissues that are closely related to the source of the primary antibody. This kit comes with rat seconda...
... The BioGenex Super Sensitive ... is a novel product ... non-biotin polymeric technology. This ... signal to noise ratio ...
... Engine Dyad thermal cycler is a ... The chassis accommodates a variety of ... which hold different types and numbers ... programming with point-and-click navigation. Peltier heat ...
Biology Products: